Join
Live feed
·
INSIDERFilingvia Quantisnow
Aptevo Therapeutics Inc. logo

Director Kunz Barbara Lopez converted options into 400 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APVO· Aptevo Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APVO (Aptevo Therapeutics Inc.) and more on Quantisnow.

Director Kunz Barbara Lopez converted options into 400 shares (SEC Form 4) | Quantisnow